| Last Price$99.88 | Day Change (%)-0.69% |
| Open Price$99.74 | Day Change ($)-0.69 |
| Day Range98.00–101.28 | 52-Week Range81.82–119.54 |
As of Thu 05/23/2013 06:20 PM EDT | USD
Good morning and welcome to the Alexion Pharmaceuticals Incorporated Fourth Quarter and Full Year 2012 Results Conference Call. Today's call is being recorded.
Good day, and welcome everyone to the Alexion Pharmaceuticals Incorporated Third Quarter 2011 Results Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Dr. Leonard Bell. Please go ahead.
Good day, ladies and gentlemen and welcome to the Alexion Pharmaceuticals Fourth Quarter 2011 Results Conference Call. My name is Alisha and I will be your operator for today. At this time, all participants are in a listen-only mode. We will conduct a question-and-answer session towards the end of ...
Good day, everyone, and welcome to the Alexion Pharmaceuticals Incorporated Third Quarter 2010 Results Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Dr. Leonard Bell, Chief Executive Officer.
Good day and welcome everyone to the Alexion Pharmaceuticals Incorporated Fourth Quarter 2010 Results Conference Call. Today's call is being recorded. At this time, for opening remarks and introductions, I would like to turn the call over to Dr. Leonard Bell. Please go ahead, sir.
Alexion Broadens and Strengthens its Executive Leadership Team
Standing out in a good year for stocks.
Buying a country or sector fund isn't as easy as it seems.